Sanofi (SNY) Beginning Cash Balance (2019 - 2026)

Sanofi has reported Beginning Cash Balance for 6 years, with the latest figure at $7.0 million in Q2 2026.

• Quarterly Beginning Cash Balance changed N/A year-over-year to $7.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $26.3 billion (up 53.68% YoY) and the FY2025 annual result came in at $8.7 billion, down 6.94% from the prior year.
• Beginning Cash Balance declined to $7.0 million in Q2 2026 per SNY's latest filing, from $9.0 billion in the prior quarter.
• Over five years, Beginning Cash Balance peaked at $9.3 billion in Q4 2024 and troughed at $7.0 million in Q2 2026.
• A 3-year average of $7.2 billion and a median of $8.7 billion in 2025 frame the typical range for Beginning Cash Balance.
• The sharpest annual moves came in 2025 and 2026: Beginning Cash Balance slipped 6.94% in 2025, then climbed 14.53% in 2026.
• Over 3 years, Beginning Cash Balance stood at $9.3 billion in 2024, then retreated by 6.94% to $8.7 billion in 2025, then tumbled by 99.92% to $7.0 million in 2026.
• According to Business Quant data, Beginning Cash Balance over the past three periods registered $7.0 million, $9.0 billion, and $8.7 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.